CRWE, OSUR, VICL, NDAQ - CRWESelect.com Stock News! Crown Equity Holdings, OraSure Technologies, Vical Inc., The NASDAQ OMX Group

Published on July 25 2012 by phathitchst0cks

Crown Equity Holdings Inc. (CRWE)

As a publishing company, CRWE has been evolving in a worldwide online multimedia advertising publisher. CRWE is paving the way in how we communicate worldwide. From buying and selling goods to how people receive news. The company's focus is on the distribution of current information to a target audience which advertisers want to reach. The Company continues to diversify and the Crown Equity family continues to expand.

Crown Equity Holdings family consist of CRWE Press Release (crwepressrelease.com), CRWE Direct (www.crwedirect.com) , CRWE AD Services (www.crwe-adservices.com), CRWE Tube (www.crwetube.com), CRWE Newswire (www.crwenewswire.com), CRWE Domains (www.crwedomains.com), and CRWE Real Estate (www.crwerealestate.com).

CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Crown Equity Holdings advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. For more information about Crown Equity Holdings Inc. visit www.crownequityholdings.com.

****

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2012 second quarter financial results and certain 2012 financial guidance for 5:00 pm ET (2:00 pm PT) on Tuesday, August 7, 2012.

An update on certain business developments will also be provided.

OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. In addition, the Company is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health. For more information about OraSure Technologies visit www.orasure.com.

****

Vical Incorporated (NASDAQ: VICL) will report financial results for the three months and six months ended June 30, 2012, before the opening of trading on Wednesday, August 1, and conduct a conference call and webcast to discuss the financial results and provide a company update at noon Eastern Time on Wednesday, August 1.

The call is open on a listen-only basis to any interested parties. The company will provide details on independent and partnered development programs in the conference call and webcast.

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at www.vical.com.

****

The Finance Committee of the Board of Directors of The NASDAQ OMX Group, Inc. (NASDAQ: NDAQ) has declared a regular quarterly dividend of $0.13 per share on the company's outstanding common stock. The dividend is payable on September 28, 2012 to shareowners of record at the close of business on September 14, 2012.

Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Finance Committee or the Board of Directors.

The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 24 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-40 microsecond speeds with 99.999% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit www.nasdaqomx.com.

To view recent article please visit http://crweselect.com/29480/stock-alerts/ccbg-cbg-dm-crwe-crweselectcom-stock-news-capital-city-bank-group-cbre-group-the-dolan-company-crown-equity-holdings/

CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the

move.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE) advertises for a particular client, Crown Equity Holdings Inc. (CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE), if paid in stock, can and may sell those securities during the advertising period.

http://crweselect.com/29483/stock-alerts/crwe-osur-vicl-ndaq-crweselectcom-stock-news-crown-equity-holdings-orasure-technologies-vical-inc-the-nasdaq-omx-group-2/